It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ASTH’s FA Score shows that 0 FA rating(s) are green while.
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ASTH’s TA Score shows that 5 TA indicator(s) are bullish.
ASTH (@Medical/Nursing Services) experienced а -8.42% price change this weekfor the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.15%. For the same industry, the average monthly price growth was -1.20%, and the average quarterly price growth was -5.36%.
ASTH is expected to report earnings on May 13, 2025.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
ASTH | ||
---|---|---|
OUTLOOK RATING 1..100 | 12 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 63 Fair valued | |
PROFIT vs RISK RATING 1..100 | 78 | |
SMR RATING 1..100 | 70 | |
PRICE GROWTH RATING 1..100 | 62 | |
P/E GROWTH RATING 1..100 | 86 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ASTH | |
---|---|
RSI ODDS (%) | 2 days ago82% |
Stochastic ODDS (%) | 2 days ago74% |
Momentum ODDS (%) | 2 days ago86% |
MACD ODDS (%) | 2 days ago75% |
TrendWeek ODDS (%) | 2 days ago73% |
TrendMonth ODDS (%) | 2 days ago76% |
Advances ODDS (%) | 10 days ago80% |
Declines ODDS (%) | 2 days ago72% |
BollingerBands ODDS (%) | 2 days ago66% |
Aroon ODDS (%) | 2 days ago81% |
A.I.dvisor indicates that over the last year, ASTH has been loosely correlated with AGL. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ASTH jumps, then AGL could also see price increases.
Ticker / NAME | Correlation To ASTH | 1D Price Change % | ||
---|---|---|---|---|
ASTH | 100% | -4.57% | ||
AGL - ASTH | 48% Loosely correlated | -2.76% | ||
AMN - ASTH | 46% Loosely correlated | +6.73% | ||
NHC - ASTH | 38% Loosely correlated | -2.77% | ||
USPH - ASTH | 37% Loosely correlated | -2.16% | ||
AIRS - ASTH | 33% Loosely correlated | -8.66% | ||
More |
A.I.dvisor indicates that over the last year, FDHT has been loosely correlated with ASTH. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if FDHT jumps, then ASTH could also see price increases.
Ticker / NAME | Correlation To FDHT | 1D Price Change % | ||
---|---|---|---|---|
FDHT | 100% | -2.34% | ||
ASTH - FDHT | 41% Loosely correlated | -4.57% | ||
PINC - FDHT | 18% Poorly correlated | -1.53% | ||
OPRX - FDHT | 14% Poorly correlated | -6.62% | ||
EVH - FDHT | 13% Poorly correlated | -2.61% | ||
PHR - FDHT | 13% Poorly correlated | -0.84% | ||
More |